|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
7,105,540 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
17,044 |
Total Sell Value |
$0 |
$0 |
$0 |
$5,919,264 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
10 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Johnson Paula A |
Director |
|
2021-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
717 |
717 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2021-04-09 |
4 |
D |
$329.75 |
$308,646 |
D/D |
(936) |
8,444 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
30 |
36,960 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
52 |
210,853 |
|
- |
|
Rolle Myron L |
Director |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
790 |
790 |
|
- |
|
Sutter Martin P |
Director |
|
2021-02-17 |
4 |
AS |
$314.01 |
$1,177,538 |
D/D |
(3,750) |
176,510 |
|
-1% |
|
Sutter Martin P |
Director |
|
2021-02-16 |
4 |
AS |
$330.67 |
$1,240,013 |
D/D |
(3,750) |
180,260 |
|
-3% |
|
Puhy Dorothy E |
Director |
|
2021-02-01 |
4 |
AS |
$345.64 |
$1,747,347 |
D/D |
(5,000) |
2,869 |
|
-12% |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2021-01-28 |
4 |
AS |
$366.00 |
$1,830,000 |
D/D |
(5,000) |
31,930 |
|
-17% |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2021-01-28 |
4 |
OE |
$66.25 |
$331,250 |
D/D |
5,000 |
36,930 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2020-12-29 |
4/A |
AS |
$321.00 |
$1,605,000 |
D/D |
(5,000) |
31,930 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2020-12-29 |
4/A |
OE |
$21.55 |
$107,750 |
D/D |
5,000 |
36,930 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2020-12-29 |
4 |
AS |
$321.00 |
$1,605,000 |
D/D |
(5,000) |
26,930 |
|
-12% |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2020-12-22 |
4 |
AS |
$296.26 |
$498,997 |
D/D |
(1,682) |
31,930 |
|
1% |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2020-12-21 |
4 |
AS |
$295.52 |
$1,618,279 |
D/D |
(5,474) |
33,612 |
|
4% |
|
Sutter Martin P |
Director |
|
2020-11-18 |
4 |
AS |
$268.34 |
$201,255 |
D/D |
(750) |
184,010 |
|
20% |
|
Sutter Martin P |
Director |
|
2020-11-17 |
4 |
AS |
$269.53 |
$202,148 |
D/D |
(750) |
184,760 |
|
15% |
|
Began Marc A |
VP & General Counsel |
|
2020-11-06 |
4 |
D |
$272.40 |
$41,677 |
D/D |
(153) |
4,471 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
55 |
210,801 |
|
- |
|
Greenfield Andrew J |
VP, Chief Commercial Officer |
|
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
43 |
39,086 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2020-08-21 |
4 |
AS |
$305.20 |
$12,253,177 |
D/D |
(40,000) |
210,746 |
|
5% |
|
Minogue Michael R |
Chairman, President, CEO |
|
2020-08-21 |
4 |
OE |
$22.44 |
$897,600 |
D/D |
40,000 |
250,746 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2020-08-20 |
4 |
AS |
$309.40 |
$18,658,744 |
D/D |
(60,000) |
210,746 |
|
2% |
|
Minogue Michael R |
Chairman, President, CEO |
|
2020-08-20 |
4 |
OE |
$22.44 |
$1,346,400 |
D/D |
60,000 |
270,746 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2020-08-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,883 |
52,555 |
|
- |
|
740 Records found
|
|
Page 7 of 30 |
|
|